1248520-97-9

Upstream product

• 1161921-99-8 (4S)-4-[4-cyano-2-(methylsulfanyl)phenyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)-phenyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid 
• 170572-49-3 2-fluoro-4-cyanotoluene 
• 1161921-92-1 4-[2-(dimethylamino)vinyl]-3-(methylsulfonyl)benzonitrile 
• 1161921-97-6 4‐formyl‐3‐(methylthio)benzonitrile 
• 105942-10-7 3-fluoro-4-formylbenzonitrile 
• 1248520-96-8 allyl 4-[4-cyano-2-(methylsulfanyl)phenyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
• 1161921-98-7 4-[4-cyano-2-(methylsulfanyl)phenyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid 
• 1161921-93-2 4-formyl-3-(methylsulfonyl)benzonitrile 
• 1161921-91-0 4-methyl-3-(methylsulfonyl)benzonitrile 

Downstream Products

• 1248520-98-0 (4S)-4-[4-cyano-2-(methylsulfanyl)phenyl]-6-methyl-2-oxo-1-[3-(trifluoromethyl)-phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile 
• 1164201-98-2 (4S)-4-{4-cyano-2-[(S)-methylsulfinyl]phenyl}-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile 
• 1164201-99-3 (4S)-4-{4-cyano-2-[(R)-methylsulfinyl]phenyl}-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile 
• 1164204-23-2 (4S)-4-{4-Cyano-2-[methylsulfinyl]phenyl}-6-methyl-3-(methylsulfonyl)-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile 
• 1248521-01-8 (SS)-N-[(5-cyano-2-{(4S)-5-cyano-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidin-4-yl}phenyl)(methyl)oxido-λ⁶-sulfanilidene]-2,2,2-trifluoroacetamide 
• 1164201-95-9 (4S)-4-{4-cyano-2-(methylsulfinyl)phenyl}-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile 

Relevant academic research and scientific papers

Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases

Human neutrophil elastase (HNE) is a key protease for matrix degradation. High HNE activity is observed in inflammatory diseases. Accordingly, HNE is a potential target for the treatment of pulmonary diseases such as chronic obstructive pulmonary disease

SULFONIC AMIDE AND SULFOXIMINE-SUBSTTTUTED DIARYL-DIHYDROPYRIMIDINONES AND USAGE THEREOF

The present application relates to novel sulfonamidw- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and als

4-(4-CYANO-2-THIOARYL)DIHYDRO PYRIMIDINONES AND THEIR USE

The present invention relates to novel 4-(4-cyano-2-thioaryl) dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing